Therefore, the EU is asking that Poland implement these regulations prior to actual membership. Poland spends about USD 175.00 annually on health care per person, of which USD 45.00 covers drug costs. The experts debate whether price increase due to EU harmonization would not be offset by the use of more effective drugs versus generics. Polish manufacturers are concerned that an over-protective attitude towards original drugs could bankrupt domestic producers of generics or seriously hamper them financially. Harmonization with EU regulations would likely force a consolidation in the Polish pharmaceutical industry.
Reimbursement is crucial for drugs used in treatment of chronic or persistent diseases.
Time schedule u new editions of all reimbursement lists are published annually. Lists of reimbursement limits are published a minimum of twice a year. Zofia Sobiepanek Commercial Specialist U.S. Commercial Service Al.